EPZ6438

Product Name: EPZ-6438

Synonyms: EPZ-6438;E-7438;EPZ-7438;N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-[1,1'-biphenyl]-3-carboxamide;[1,1'-Biphenyl]-3-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-;N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-[1,1'-biphenyl]-3-carboxamide EPZ6438

CAS: 1403254-99-8

MF: C34H44N4O4

MW: 572.73756

Usage : EPZ-6438 is a potent, and selective EZH2 inhibitor with Ki and IC50 of 2.5 nM and 11 nM in cell-free assays, exhibiting a 35-fold selectivity versus EZH1 and >4,500-fold selectivity relative to 14 other HMTs.

In vitro:

EPZ-6438 concentration-dependently reduces global H3K27Me3 levels in wild-type or SMARCB1 mutant cells, and induces strong antiproliferative effects with IC50 ranging from 32 nM to 1000 nM in SMARCB1-deleted MRT cell lines. EPZ-6438 induces gene expression of neuronal differentiation and cell cycle inhibition, while inhibtis expression of Hedgehog pathway genes, MYC and EZH2. The antiproliferative effect of EPZ-6438 is enhanced by either prednisolone or dexamethasone in several EZH2 mutant lymphoma cell lines.

In vivo:

In SCID mice bearing s.c. G401 xenografts, EPZ-6438 induces tumor stasis during the administration period and produces a significant tumor growth delay with minimal effect on body weight.

Related Histone Methyltransferase Products :

GSK126 CAS: 1346574-57-9

EPZ015666 CAS: 1616391-65-1

MI-2 (Menin-MLL Inhibitor) CAS: 1271738-62-5

3-deazaneplanocin A (DZNeP) HCl CAS: 120964-45-6

GSK343 CAS: 1346704-33-3

EPZ5676 CAS: 1380288-87-8

BIX 01294 CAS: 935693-62-2

EPZ004777 CAS: 1338466-77-5

UNC1999 CAS: 1431612-23-5

MM-102 CAS: 1417329-24-8

Panobinostat (LBH589) CAS: 404950-80-7

Y-27632 2HCl CAS: 146986-50-7